News and Publications

This study aims to determine if a portable VHC could improve MART therapy effectiveness outside of the home. 

Expert insights from UK respiratory specialists and school nurses on fall and winter asthma triggers and advancements in asthma care and innovative technologies supporting better management among children and adolescents.

This study was presented at the American Thoracic Society Conference in 2023.

Given the more recent availability of mucus plug detection as part of the FRI technology, we wanted to investigate this association further.

This study assessed people with COPD suffering with mucus hypersecretion, post exacerbation in Wales, UK, following treatment with a handheld, OPEP device or the ACBT breathing technique.

Short-acting beta2 agonist (SABA) monotherapy is typically required to provide as needed short term relief of bronchoconstriction. The salbutamol EasyHaler† DPI has recently become available in the UK as an alternative to delivery by pressurized metered-dose inhaler. Our study evaluated delivery from this DPI at different inhalation flow rates.

Medikro to distribute Aerobika* OPEP Devices to patients in Finland and Sweden.

Various improvements have been made to the basic jet nebulizer design with the intent of delivering more medication to the distal airways while still providing aerosol within the respirable range of 3 – 5 μm.

This study was presented at CHEST Conference 2023. 

This study was presented at CHEST Conference 2023. 

This study was presented at CHEST Conference 2023. 

Development of a Prototype Patient Respiratory Management Mobile Health Application Using Validated Tools to Assess User Experience

Positioning of the tongue during inhaler medication delivery is something that is not thought about by either users or caregivers.

More consistent dose delivery was achieved with the breath actuated technology rather than breath enhanced. Delivering medication only when the patient inhales would result in more stable therapy if I:E ratio was to change with disease< progression or if the patient took breaks to talk during treatment.

Online marketplaces offer convenience and a vast array of options making them an attractive choice for purchasing medical devices. 

Does Spacer/Adapter Device Choice Affect Delivery of a Pressurized Metered Dose Inhaler (pMDI) through a Humidified Circuit to a Simulated Patient on Mecha

Does Spacer/Adapter Device Choice Affect Delivery of a Pressurized Metered Dose Inhaler (pMDI) through a Humidified Circuit to a Simulated Patient on Mecha

This lab study compared a number of VHCs for patient usability and safety factors. 

This lab study compared a number of VHCs for patient usability and safety factors. 

Asthma control and global warming are important issues that have significant impacts on human health and the environment.

It is critical however to ensure that maintaining or improving the patient’s asthma control goes hand in hand with environmental actions.

This lab study investigated how to optimize the modelled lung delivery while at the same time minimizing the carbon emissions from the MDI.

Asthma control and global warming are important issues that have significant impacts on human health and the environment.

It is critical however to ensure that maintaining or improving the patient’s asthma control goes hand in hand with environmental actions.

This lab study investigated how to optimize the modelled lung delivery while at the same time minimizing the carbon emissions from the MDI.

More consistent dose delivery was achieved with the breath actuated technology rather than breath enhanced.
Delivering medication only when the patient inhales would result in more stable therapy if I:E ratio was to change with disease< progression or if the patient took breaks to talk during treatment.

More consistent dose delivery was achieved with the breath actuated technology rather than breath enhanced. Delivering medication only when the patient inhales would result in more stable therapy if I:E ratio was to change with disease< progression or if the patient took breaks to talk during treatment.

This study was presented at the ERS International Congress from September 9-13, 2023. 

This study was presented at the ERS International Congress from September 9-13, 2023.